Jazz Pharmaceuticals
JAZZ
#2166
Rank
NZ$12.76 B
Marketcap
$211.07
Share price
-1.20%
Change (1 day)
3.24%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.48. In 2022 the company made an earnings per share (EPS) of -$6.22 an increase over its 2021 EPS that were of -$9.46.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-65.75%
2022-$6.22-34.2%
2021-$9.46-224.83%
2020$7.58-53.25%
2019$16.2123.59%
2018$13.11-8.24%
2017$14.2923.74%
2016$11.5522.12%
2015$9.46478.49%
2014$1.63-74.93%
2013$6.52-27.11%
2012$8.9569.1%
2011$5.29245.98%
2010$1.53-462.5%
2009-$0.42-96.7%
2008-$12.80-27.04%
2007-$17.5465.47%
2006-$10.60-4.59%
2005-$11.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.07 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$14.57-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.57-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.52 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel